The major owners of Ascelia Pharma AB include:

Sunstone Capital is an early-stage Life Science and Technology venture capital company investing in European start-up companies with strong potential to achieve global success in their markets. With approximately EUR 700 million in funds Sunstone is one of the leading and most active independent venture capital investors in the Nordic market. Sunstone Capital has a strong portfolio totaling 50 companies and has completed several successful trade sales and IPOs.

Øresund Healthcare Management AS is a venture capital firm specializing in early stage, expansion capital, and start up investments in healthcare services, medical device, diagnostics and instruments within the pharmaceuticals and biotechnology sectors.